Home | Welcome to Contract Pharma   
Last Updated Saturday, April 18 2015

Print

Breaking News

Related Searches: R&D Development Phase II formulation
February 24, 2015
Will manufacture AB-022 for the treatment of cardiovascular diseases  Read More »
February 24, 2015
Gains Phase III drug for gastrointestinal disease  Read More »
February 23, 2015
Will develop TGF beta receptor kinase inhibitors  Read More »
February 23, 2015
Merck to purchase 15% equity stake in NGM  Read More »
February 23, 2015
Namchuk responsible for advancing the early-stage product pipeline  Read More »
February 23, 2015
Expands immuno-oncology pipeline  Read More »
February 23, 2015
Secures long-term lease in Bannockburn, IL  Read More »
February 23, 2015
BBSRC competition invests £20M to bring innovative biotechnology projects to market  Read More »
February 23, 2015
Expands filtration platform for life sciences and biopharma segments  Read More »
February 23, 2015
Dermatology sales were up 70% in the quarter  Read More »
February 23, 2015
Gains leading gastrointestinal franchise  Read More »
February 20, 2015
To use TBK1 to study ALS disease mechanisms and screen for drug candidates  Read More »
February 20, 2015
Adds corporate affairs and corporate development functions  Read More »
February 20, 2015
AMPLEX and PREFIX are ready for Phase III  Read More »
February 20, 2015
Brandicourt succeeds ousted Viehbacher  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On